Vanda Pharmaceuticals Inc — Dividend History & Yield (NASDAQ:VNDA) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Dividends per share —————— — Dividend yield % —————— — Payout ratio % —————— —

Noticias

La FDA acepta la solicitud de imsidolimab de Vanda para trastorno cutáneo raro

Vanda Pharmaceuticals Breaks Through With FDA Approval, Decision Date For Skin Drug - Vanda Pharmaceuticals (NASDAQ:VNDA)

American Express, Oracle among market cap stock movers on Monday

H.C. Wainwright eleva el precio objetivo de Vanda Pharmaceuticals a 24 dólares tras aprobación de la FDA

H.C. Wainwright eleva precio objetivo de Vanda Pharma a $24 tras aprobación FDA

Vanda Pharmaceuticals stock price target raised to $24 by H.C. Wainwright on FDA approval

Las acciones de Vanda Pharmaceuticals se disparan un 33 %; Aquí están 20 acciones que se mueven en premercado | Benzinga España

Why Is Vanda Pharmaceuticals Stock Soaring On Monday? - Vanda Pharmaceuticals (NASDAQ:VNDA)

Stock Market Today: Dow Jones, S&P 500 Futures Drop After Supreme Court Strikes Down Trump's Emergency Tariffs— Novo Nordisk, Strategy, Vanda In Focus - State Street SPDR S&P 500 ETF Trust (ARCA:SPY)

Acciones de Vanda Pharmaceuticals suben tras aprobación de la FDA

Vanda Pharmaceuticals stock surges after the FDA approves its new Bipolar I drug

La FDA aprueba Bysanti de Vanda para trastorno bipolar y esquizofrenia